drugset / Trial / NCT00115037
Managing Alcoholism in People Who Do Not Respond to Naltrexone
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study involving treatment for alcohol dependence (alcoholism). The study will combine motivational enhancement therapy and cognitive behavioral therapy (combined behavioral intervention, or CBI) and tests the benefits of continued/discontinued treatment with naltrexone in a randomized placebo-controlled trial. CBI may have advantages in motivating patients to greater medication adherence and may address psychosocial factors that may limit the effects of naltrexone.
Timeline
- Start
- 2003-09
- Primary completion
- 2008-04
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 100 mg | — |